Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

45.22
+0.56001.25%
Post-market: 44.94-0.2800-0.62%16:55 EDT
Volume:2.93M
Turnover:132.39M
Market Cap:3.60B
PE:-12.04
High:45.92
Open:44.28
Low:43.91
Close:44.66
Loading ...

Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?

Zacks
·
04 Mar

Analysts Offer Insights on Healthcare Companies: Akero Therapeutics (AKRO), Immunovant (IMVT) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
03 Mar

Akero Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
03 Mar

Promising Developments and Strong Financial Position Support Buy Rating for Akero Therapeutics

TIPRANKS
·
03 Mar

Akero Therapeutics price target lowered to $90 from $96 at Morgan Stanley

TIPRANKS
·
03 Mar

Bank of America Securities Remains a Buy on Akero Therapeutics (AKRO)

TIPRANKS
·
02 Mar

Akero Therapeutics: Buy Rating Backed by Groundbreaking Clinical Results and Strong Financial Position

TIPRANKS
·
02 Mar

Akero Therapeutics Reports Promising Clinical Trial Results

TIPRANKS
·
01 Mar

Akero Therapeutics: Strong Financial Health and Promising Clinical Trial Results Drive Buy Rating

TIPRANKS
·
01 Mar

Akero Therapeutics Inc - Q4 Shr Loss $0.99

THOMSON REUTERS
·
28 Feb

Akero Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Akero Therapeutics Q4 Loss Unchanged

MT Newswires Live
·
28 Feb

Earnings Flash (AKRO) Akero Therapeutics Posts Q4 Total Operating Expenses $78M

MT Newswires Live
·
28 Feb

Is Akero Therapeutics Inc. (AKRO) the Best Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
28 Feb

Phillip Securities Reaffirms Their Buy Rating on Akero Therapeutics (AKRO)

TIPRANKS
·
24 Feb

Akero Therapeutics, Inc. (AKRO): the Best Performing Pharma Stock So Far in 2025

Insider Monkey
·
24 Feb